Anemia Management in Chronic Kidney Disease Not on Dialysis Patients After the European Renal Best Practice (ERBP) Working Group Recommendations
Anemia Management in Chronic Kidney Disease Not on Dialysis Patients After the European Renal Best Practice (ERBP) Working Group Recommendations
The purpose of this study is to evaluate the impact of the last recommendations of the
 European Anemia Working Group ERBP in the anemia management in the achievement of the
 therapeutic goal of Hb 11-12 g/dL.
Inclusion Criteria:

 -  Adults patients with anemia secondary to chronic kidney disease (CKD) not on dialysis.

 -  Patients starting anemia treatment (naïve) after six months of the last
 recommendations of the European Anemia Working Group ERBP (January 2011).

 -  Patients in treatment who changed from previous ESA treatment since January 2011
 (converted patients

 Exclusion Criteria:

 -  Patients in Erythropoiesis Stimulating Agents (ESA) dose adjustment period.

 -  Kidney transplant patients.